XML 39 R29.htm IDEA: XBRL DOCUMENT
v3.23.1

Related Party Transactions (Details) - USD ($) |  | 9 Months Ended |
--- | --- | --- | ---
Mar. 27, 2023 | Mar. 31, 2023 | Mar. 31, 2022 | Jun. 30, 2022
Related Party Transaction |  |  |  |
Royalties on sales (in percent) |  | 70.00% |  |
TheraCour Pharma Inc |  |  |  |
Related Party Transaction |  |  |  |
Percentage of direct costs |  | 30.00% |  |
Other general and administrative expense |  | $ 2,000 |  |
Percentage of net sales allocated for royalty payments |  | 15.00% |  |
Accounts payable |  | $ 708,881 |  | $ 679,397
Accounts payable offset by advance |  | 465,000 |  | 465,000
Accrued royalties |  | $ 0 |  | $ 0
Karveer Meditech, Pvt., Ltd |  |  |  |
Related Party Transaction |  |  |  |
Clinical trials manager fee (in percent) | 30.00% |  |  |
Royalties on sales (in percent) | 70.00% |  |  |
Series A Preferred stock | COVID 19 License Agreement | Board of Directors Chairman |  |  |  |
Related Party Transaction |  |  |  |
License milestone payments |  |  | $ 935,088 |
Series A Preferred stock | COVID 19 License Agreement | Board of Directors Chairman | TheraCour Pharma Inc |  |  |  |
Related Party Transaction |  |  |  |
Number of shares authorized |  |  | 100,000 |

X
- Definition Amount for accounts payable offset by advance. + References No definition available. + Details
Name: | nnvc_AccountsPayableOffsetByAdvance
Namespace Prefix: | nnvc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of license milestone payments. + References No definition available. + Details
Name: | nnvc_LicenseMilestonePayments
Namespace Prefix: | nnvc_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage of clinical trials manager fee. + References No definition available. + Details
Name: | nnvc_PercentageOfClinicalTrialsManagerFee
Namespace Prefix: | nnvc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of direct costs. + References No definition available. + Details
Name: | nnvc_PercentageOfDirectCosts
Namespace Prefix: | nnvc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalty expense calculated as a percentage of net sales. + References No definition available. + Details
Name: | nnvc_PercentageOfNetSalesAllocatedForRoyaltyPayments
Namespace Prefix: | nnvc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of royalties on sales. + References No definition available. + Details
Name: | nnvc_PercentageOfRoyaltiesOnSales
Namespace Prefix: | nnvc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.15(a)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.15(5)) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878 + Details
Name: | us-gaap_AccountsPayableCurrentAndNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.15(a)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.15(5)) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878 + Details
Name: | us-gaap_AccruedRoyaltiesCurrentAndNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of general and administrative expense classified as other. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 + Details
Name: | us-gaap_OtherGeneralAndAdministrativeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares authorized for issuance under share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nnvc_TheracourPharmaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=nnvc_KarveerMeditechPvt.LtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=nnvc_Covid19LicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |